Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Cash from Investing Activities (2020 - 2022)

Historic Cash from Investing Activities for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q4 2022 value amounting to $33.5 million.

  • Atea Pharmaceuticals' Cash from Investing Activities changed N/A to $33.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$455.4 million, marking a year-over-year change of. This contributed to the annual value of $56.1 million for FY2024, which is 3920.8% up from last year.
  • Per Atea Pharmaceuticals' latest filing, its Cash from Investing Activities stood at $33.5 million for Q4 2022.
  • Atea Pharmaceuticals' Cash from Investing Activities' 5-year high stood at $33.5 million during Q4 2022, with a 5-year trough of -$487.0 million in Q3 2022.